Navigation Links
Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
Date:3/17/2008

CANTON, Mass., March 17 /PRNewswire/ - Organogenesis, Inc., announced today that Damien Bates, MD, PhD, FRACS (Plast.), has joined the company as vice president of medical affairs.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM095)

Dr. Bates combines more than twelve years of surgical practice with solid regenerative medicine industry experience. He has practiced in orthopedic, dermatologic, vascular, oncologic and general surgery, infectious diseases and intensive care, both in the U.S. and Australia. An accomplished board-certified plastic and reconstructive surgeon, Dr. Bates will serve an important and multi-faceted role within Organogenesis. In addition to leading the company's clinical study department, Dr. Bates will strengthen Organogenesis' links to the surgical community. He will also impact patient lives by collaborating with Organogenesis research and development teams to guide new product development from lab science through to approved products.

"This is an exciting time for Organogenesis, and Damien's appointment serves to solidify our executive team," said Geoff MacKay, chief executive officer of Organogenesis. "Damien's wealth of experience in tissue engineering, stem cell biology and surgical wound healing is a great fit for Organogenesis as we grow our company, as well as our product pipeline."

Organogenesis is in the midst of a large expansion, both in employees as well as facilities, and also recently acquired the electro-spinning platform technology company NanoMatrix. The company is currently developing a number of new products, and recently launched the first-ever direct-to-consumer (DTC) educational campaign for a living cell therapy (its flagship product Apligraf(R)).

Prior to joining Organogenesis, Dr. Bates served as attending plastic and reconstructive surgeon for the University of Colorado, The Children's a
'/>"/>

SOURCE Organogenesis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. STERIS Corporation Names Michael J. Tokich Chief Financial Officer
2. Take Care Health Systems Names Butler, Shine, Stern & Partners as First Marketing Agency of Record
3. Study names 5 factors of social ills in energy, mining and logging communities
4. Cardinal Health Names Michael C. Kaufmann to Lead Pharmaceutical Segment
5. Nellson Nutraceutical Names New Directors and Interim Chief Executive Officer
6. EaglePicher Medical Power Names Joseph Marotta Vice President of Sales and Marketing
7. Independent Survey Names CyberKnife(R) System Most Widely Used Extracranial Radiosurgery Technology
8. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
9. Numira Biosciences Names New Board Member
10. Senior Lifestyle Corporation Names John Cobb as President and CEO
11. Women Health Care Executives Names Genomic Health President Kimberly Popovits as Woman of the Year

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...on an emotional rollercoaster, study finds , ...it the fear factor meets the jubilant sports fan. ...ially those who root for the winning team -- enjoy...sted match and victory was in doubt, producing fee... this Thanksgiving weekend as you,re glued to the ...
(Date:11/26/2009)...David Kim of the Live Life Again Center, a practic... of a growing number of physicians who are taking...onnect with individuals who are interested in surg.... Dr. Kim is utilizing Facebook to share before-an...with the community. , Dal...
(Date:11/26/2009)...on Communications announces a highly effective and...rs struggling to make an economic recovery. , ...Flu fears is the type of challenge that could send...ding to Dr. David Benton, business growth expert a...stem – The Rfactor Intensive . “Fea...
(Date:11/25/2009)... 25 When most people he...But a chiropractor can also give patients the help... Joint, which is where your jaw (mandible) contact... The most common symptoms associated with TMJ dysf... of the jaw. But many other symptoms can be cause...
(Date:11/25/2009)...f., Nov. 25 Onyx Pharm...that the company will host two investor events in ... 7, 2009 - 9:00 a.m. CT/10:00 a.m. ET ,, Prin...s surrounding carfilzomib in relapsed and/or refra...erican Society of Hematology (ASH) Annual Meeting ...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...e the way to new methods for studying and finding ...of death in industrialized countries, according to...at mutations in a molecular channel found in heart...rolled in the cell could lead to new heart disease...
...rprises. They don't scrape and poke. They massage ... prescribe homeopathic remedies//. Of course...nded colleagues sceptical. Sometimes, there's only...ral Medicine Dentists. The important steps come be...
... higher than national guidelines recommend that, i...ening//, according to a study published in the iss...rican Academy of Neurology. The study of 1,...ines. TIA happens when blood flow to part of the b...
...the risk of becoming infected with tuberculosis (T...B disease//, according to an analysis of previousl...ine. About one-third of the world’s populatio...und information in the article. Active tuberculosi...
...nib, marketed by London company AstraZeneca PLC// ... of lung cancer in whom the first-line treatment h... 20 sites. The patients who have a recorded a... line treatment. Says Medical Science Director...
...d with a brain tumor which is at the stem of her b...to approach the doctor who after routine tests rev...ble brain tumor. The doctors have given her three ...r. According to the doctors, there is a 20 % chanc...
Other Medicine News:Health News:Fruit Flies May Pave Way to New Treatments for Age-related Heart Disease 2Health News:Fruit Flies May Pave Way to New Treatments for Age-related Heart Disease 3Health News:Homeopathy and Hypnosis Come to Dentistry 2Health News:Cholesterol in Stroke Patients Exceeds National Guidelines 2Health News:Susceptibility to TB is High Among the Smokers 2
(Date:11/25/2009)..., WEST PALM BEACH, Fla., Nov. 25 /PRNewswire-First...red Americans, especially the 27 million living wi...be all that happy, says audiologist Cindy Beyer. ,...Amex: EAR ), one of America,s largest hearing car...linked hearing loss to stress, frustration, and so...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportlink... is available in its catalogue: ,, United Stat... 2015 ,, http://www.reportlinker.com/p0158733...Forecasts-to-2015.html ,, United States Dental..., Summary ,, This report is an essential sou...
(Date:11/25/2009)... , SAN DIEGO, Nov. 25 /PRNewswire-FirstCall/ ...ce company focused on developing products for mini..., announced today that it will host a conference c.../ 2:30 p.m. PT. The conference call will focus on...Company,s products and will include comments from ...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4 2415 million stimulus award creates national consortium for revealing scientific resources 10601 1 2415 million stimulus award creates national consortium for revealing scientific resources 10601 2 2415 million stimulus award creates national consortium for revealing scientific resources 10601 3Developmental drug may help bone fractures heal after radiation exposure 60527 1Delays in Lung Cancer Care More Common in Public Hospitals 60523 1
...studies presented at the National Lipid ...RSIPPANY, N.J., May 30 Daiichi Sankyo, Inc.,annou...ee pivotal studies,demonstrated that the addition ...es treatment regimens can lower A1C in patients wi...analyses included all patients receiving,Welchol i...
...N,PHARMACEUTICALS, INC. (Nasdaq: VION ) today ann...ead anticancer agent Cloretazine(R) (VNP40101M) in...ed in posters at the 2008,American Society of Clin...Illinois., The poster (Abstract #7051) entitled "... III study of high-dose continuous infusion cytosi...
Other Medicine Technology:Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 2Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 3Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 4Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 5Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 6Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting 2Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting 3
Universal Adaptor Sleeve
...or biatrial stimulation. This is the first implant...ages. The patients benefit from a lasting improvem... against cardiac remodeling. Tupos LA uses biatria...symptomatic and medicine resistant atrial tachycar...
...ronization therapy defibrillator provides ventricu...ization therapy. Features: Independently programma...V) pacing and sensing. Designed to reduce irregula...rhythmias. Designed to maintain atrial-tracked ven...
...ronization therapy defibrillator provides ventricu...ization therapy. Features: Independently programma...V) pacing and sensing. Designed to reduce irregula...rhythmias. Designed to maintain atrial-tracked ven...
Medicine Products: